Teleflex(US:TFX) ZACKSยท2024-07-31 14:20Core Viewpoint - Analysts project that Teleflex will report quarterly earnings of $3.33 per share, reflecting a decline of 2.4% year over year, with revenues expected to reach $763.39 million, an increase of 2.7% from the same quarter last year [10] Revenue Estimates - 'Net Revenues- Anesthesia' is estimated to be $104.01 million, indicating a change of +3.2% from the year-ago quarter [2] - 'Geographic Revenues- EMEA' is expected to be $157.16 million, showing a change of +6.3% from the year-ago quarter [3] - 'Net Revenues- Interventional Urology' is projected at $83.48 million, reflecting a change of +7.3% from the prior-year quarter [5] - 'Net Revenues- Surgical' is forecasted to reach $111.50 million, indicating a change of +5.2% from the prior-year quarter [6] - 'Revenues- OEM (Original Equipment Manufacturer and Development Services)' is estimated at $88.27 million, suggesting a change of +5% year over year [8] - 'Geographic Revenues- Americas' is likely to reach $432.19 million, indicating a change of +1.8% year over year [9] - 'Net Revenues- Interventional' is estimated at $137.89 million, reflecting a change of +10.5% year over year [11] - 'Net Revenues- Other' is projected to be $55.13 million, indicating a change of -27.5% year over year [12] - 'Net Revenues- Vascular Access' is expected to reach $181.31 million, showing a year-over-year change of +4.3% [14] - 'Geographic Revenues- Asia' is forecasted to be $87.90 million, indicating a change of +1.4% from the year-ago quarter [15] Earnings Estimate Revisions - Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter, indicating that analysts have not changed their initial forecasts during this period [4] Stock Performance - Teleflex shares have experienced a change of +5.4% in the past month, compared to a -0.4% move of the Zacks S&P 500 composite, with a Zacks Rank 3 (Hold) suggesting that TFX is expected to mirror overall market performance in the near future [7]